Encapsulate Bio vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Encapsulate Bio develops tumor-on-a-chip microfluidic platforms that test patient-derived tumor samples against cancer therapies to guide personalized treatment selection; early-stage biotech focused on ex vivo drug sensitivity testing for oncology.
About
Encapsulate Bio is an early-stage biotechnology company focused on advancing personalized cancer medicine through its proprietary tumor-on-a-chip platform. The technology creates miniaturized, microfluidic three-dimensional models of patient-derived tumors — capturing the complex cellular architecture and microenvironment of real cancer tissue — and exposes these microtumors to panels of therapeutic agents to generate rapid, clinically relevant drug sensitivity data. The goal is to give oncologists predictive, patient-specific treatment guidance before committing to a full course of chemotherapy or targeted therapy, reducing the trial-and-error approach that currently characterizes much of oncology treatment selection.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.